The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a …
A Adams, S Blawatt, T Magel, S MacDonald… - … , Prevention, and Policy, 2023 - Springer
Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on
take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods …
take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods …
Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study
E Oviedo-Joekes, S Dobischok, J Carvajal… - BMC Health Services …, 2023 - Springer
Background To support public health measures during the COVID-19 pandemic, oral opioid
agonist treatment (OAT) take-home doses were expanded in Western countries with positive …
agonist treatment (OAT) take-home doses were expanded in Western countries with positive …
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis
ME Socias, JC Choi, N Fairbairn, C Johnson… - International Journal of …, 2023 - Elsevier
Background In anticipation of COVID-19 related disruptions to opioid use disorder (OUD)
care, new provincial and federal guidance for the management of OUD and risk mitigation …
care, new provincial and federal guidance for the management of OUD and risk mitigation …
Socioeconomic consequences of the COVID‐19 pandemic for people who use drugs
The COVID‐19 pandemic triggered widespread socioeconomic hardship, disproportionately
impacting disadvantaged populations. People who use illicit drugs are more likely to …
impacting disadvantaged populations. People who use illicit drugs are more likely to …
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
A Conway, AD Marshall, S Crawford, J Hayllar… - Implementation …, 2023 - Springer
Background Deimplementation, the removal or reduction of potentially hazardous
approaches to care, is key to progressing social equity in health. While the benefits of opioid …
approaches to care, is key to progressing social equity in health. While the benefits of opioid …
Health Crisis or Crime Surge? Assessing the Asymmetric Nexus Between Pandemic Uncertainty and Drug-Related Crimes
X Cao, Z Cui, S Ali, R Nazar - Crime & Delinquency, 2024 - journals.sagepub.com
The current investigation examines the asymmetric influence of pandemic uncertainty on
drug-related crimes in the top 10 countries with a highest prevalence of such offenses …
drug-related crimes in the top 10 countries with a highest prevalence of such offenses …
Time for Australia to increase take away doses in opioid agonist treatment
G FitzGerald, P MacCartney, J Cook, S Crawford… - International Journal of …, 2024 - Elsevier
Abstract Opioid Agonist Treatment is the cornerstone of minimising harms related to opioid
use, however its uptake is limited by a tightly regulated and stigmatising treatment …
use, however its uptake is limited by a tightly regulated and stigmatising treatment …
[DOC][DOC] Post-market Review of PBS Opioid Dependence Treatment Program medicines
AAE Price, HIVHI Virus, MBSMB Schedule, NH Act… - pbs.gov.au
INTERIM Pharmaceutical Benefits Scheme Post-market Review of PBS Opioid Dependence
Treatment Program medicines Report to the Pharmaceutical Benefits Advisory Committee March …
Treatment Program medicines Report to the Pharmaceutical Benefits Advisory Committee March …